0000950170-24-001827.txt : 20240104 0000950170-24-001827.hdr.sgml : 20240104 20240104160053 ACCESSION NUMBER: 0000950170-24-001827 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morich Frank CENTRAL INDEX KEY: 0001748615 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 24511699 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 ownership.xml 4 X0508 4 2024-01-02 false 0001645460 Cue Biopharma, Inc. CUE 0001748615 Morich Frank C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 true false false false false Stock Option (right to buy) 2.78 2024-01-02 4 A false 24400 0.0 A 2034-01-01 Common Stock 24400 24400 D Represents a stock option award granted pursuant to the Issuer's Director Compensation Policy. This option was granted on January 2, 2024. The shares underlying the option are scheduled to vest in full on the anniversary date of the grant date. /s/ Frank Morich by Colin Sandercock, attorney-in-fact 2024-01-04